BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05633979-completion@plaintrial.com
DTSTAMP:20260926T161620Z
DTSTART;VALUE=DATE:20321231
SUMMARY:Phase 1b Study of EZH1/2 Inhibitor Valemetostat in Combination With
  Trastuzumab Deruxtecan in Subjects With HER2 Low/Ultra-low/Null Metastati
 c Breast Cancer — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT05633979
URL:https://plaintrial.com/trial/NCT05633979
END:VEVENT
END:VCALENDAR